ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2025
Association Between Social Vulnerability and Clinical Outcomes After Proximal Aortic Surgery.
Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anxiety, depression and health-related quality of life in patients with thoracic aortic disease: a longitudinal study in a cardiothoracic outpatient clinic.Frontiers in cardiovascular medicine · 2026Article
- Embryological Divergence and Molecular Mechanisms in Thoracic and Abdominal Aortic Aneurysms: Bridging Developmental Biology and Clinical Insights.Biomolecules · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesTo evaluate the relationship between social vulnerability and proximal aortic surgery outcomes.
methodsSingle-centre, social vulnerability index (SVI)-stratified, cohort study including all patients undergoing primary proximal aortic surgery from 1997 to 2023. Social vulnerability index was calculated by patient residential Zone Improvement Plan (ZIP) code. Outcomes of interest were postoperative major adverse events (operative mortality, myocardial infarction, stroke, reoperation, haemodialysis, and tracheostomy) and all-cause mortality at time of last registry assessment.
resultsOf the 2002 patients, 659 (32.9%) had SVI <0.25, 727 (36.3%) had SVI 0.25to <0.50, 338 (16.9%) had SVI 0.50 to <0.75, and 278 (13.9%) had SVI ≥0.75. Patients with SVI ≥0.75 had more comorbidity (diabetes, smoking, chronic obstructive pulmonary disease, prior stroke, renal insufficiency, and New York Heart Association class III-IV heart failure), as well as more dissection at presentation and non-elective surgery, compared with lower-SVI patients. Operative mortality occurred in 8/2002 (0.40%) patients and the composite of major adverse events occurred in 99/2002 (4.9%) patients. On multivariable analysis, SVI was not significantly associated with major adverse events (odds ratio for SVI ≥0.75: 1.09, 95% confidence interval [CI] 0.56-2.06; P = .80). At median follow-up of 8.3 years (95% CI 4.3-14.0), 204 (10.2%) patients had died; patients with SVI ≥0.75 had the highest all-cause mortality (SVI <0.25: 49/659 [7.4%], SVI 0.25 to <0.50: 69/727 [9.5%], SVI 0.50 to <0.75: 41/338 [12.1%], SVI ≥0.75: 45/278 [16.2%]; P = .001). After multivariable adjustment for confounders, SVI was not significantly associated with all-cause mortality (hazard ratio for SVI ≥0.75: 1.29, 95% CI 0.90-1.85; P = 0.17).
conclusionsPreoperative SVI is not independently associated with early or late outcomes after surgery of the proximal aorta, despite the most vulnerable patients having the highest long-term mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.